Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Registrant anticipates that it will file the Quarterly Report no later than the fifth calendar day
Innovation Pharmaceuticals Inc. (the “Registrant”) was unable, without unreasonable effort or expense, to file its Quarterly Report on Form 10-Q (the “Quarterly Report”) for the period ended December 31, 2020 (the “Reporting Period”) by the February 16, 2021 filing due date applicable to non-accelerated filers due to a delay experienced by the Registrant in preparing disclosure relating to recent developments regarding clinical trials for the Registrant’s lead drug compound, and in particular, developments on or around the filing due date relating to clinical trials in the United States and Russia. The Registrant anticipates that it will file the Quarterly Report no later than the fifth calendar day following the prescribed filing due date.
No their not creating a race war, they begin the race war shortlt after the Civil War, when they created the KKK.
https://www.thedailybell.com/all-articles/news-analysis/yes-democrats-did-start-the-ku-klux-klan-and-its-still-the-party-of-racism/
Over 100 million new users joined Telegram this January, seeking more privacy and freedom. But what about the messages and memories that remain in older apps?
Starting today, everyone can bring their chat history – including videos and documents – to Telegram from apps like WhatsApp, Line and KakaoTalk. This works both for individual chats and groups:
https://telegram.org/blog/move-history
:) :) you want to compare profiles? :) My first investment in CTIX 2008 because of Kevetrin.
Dp70 also posted the next eventful date to watch for:
"Feb 28 – possible news about status of trial and possible news regarding foreign trial or dealings with foreigners regarding B. (Mars in 9th house rules publications, dealings with foreign countries). The money prospects of the company steadily increase through March which could be in the form of grants, collaborations, increase in stockholders."
Feb 9th dp70 released another Astrology report I found interesting thought I would share a bit of it just for chart comparsion:
All dates posted have an influence of +/- 1 day (weekends excluded as news doesn’t typically come out on weekends).
Feb 12 – possible sp increase with Venus aspect to Venus/Jupiter. More news articles being found about IPIX and B.
"SC 13G Statement of acquisition of beneficial owners... 2021-02-11"
Feb 16 – IPIX/B gain recognition. This may not be in the form of PR but positive results could start to be seen by those with access to the participants. Increase in sp and value of company could be seen.
NT 10-Q Notification of inability to timely file 2021-02-17
Trading is good but I am somewhat suspecious because it also happened back in June, less than a year ago.
Don't want any more term sheets I want to know what the bottom line is :)
Been here a year, never went up like this, huh? Tell us more after looking at this chart for June 2020: https://finance.yahoo.com/quote/IPIX?p=IPIX
Thanks NYBob, great catch, Best president of our lifetime.
Dr Bones translate:ICH harmonised guideline integrated addendum to ICH E6(R1): Guideline for Good Clinical Practice ICH E6(R2) ICH Consensus Guideline
International Conference on Harmonisation of technical requirements for registration of pharmaceuticals for human use.
A standard for the design, conduct, performance, monitoring, auditing, recording, analyses, and reporting of clinical trials that provides assurance that the data and reported results are credible and accurate, and that the rights, integrity, and confidentiality of trial subjects are protected. Ethical and scientific quality standards for designing, conducting, recording and reporting trials that involve participation of human subjects to ensure that the rights, safety and wellbeing of the trial subjects are protected. Ensure the credibility of clinical trial data.
TABLE OF CONTENTS
INTRODUCTION TO ICH GCP
1. GLOSSARY
2. THE PRINCIPLES OF ICH GCP
3. INSTITUTIONAL REVIEW BOARD/INDEPENDENT ETHICS COMMITTEE (IRB/IEC)
4. INVESTIGATOR
5. SPONSOR
6. CLINICAL TRIAL PROTOCOL AND PROTOCOL AMENDMENT(S)
7. INVESTIGATOR’S BROCHURE
8. ESSENTIAL DOCUMENTS FOR THE CONDUCT OF A CLINICAL TRIAL
Clinical Research News
Feb 17 US University evaluates Long Term Cardiovascular and Pulmonary Complications After COVID-19 With Point of Care Ultrasound
Feb 17 Sinonasal Cancer Multi-institution Study begins in United States
Feb 16 Biopharmaceutical company studies a Safety and Tolerability of Abelacimab vs. Rivaroxaban in Patients With Atrial Fibrillation
Feb 16 FDA Approves Drug to Reduce Bone Marrow Suppression Caused by Chemotherapy
Feb 16 WHO launches consolidated guidelines for malaria
Feb 16 EMA starts rolling review of CureVac’s COVID-19 vaccine (CVnCoV)
Feb 16 WHO lists two additional COVID-19 vaccines for emergency use and COVAX roll-out
Feb 15 CDC Food Safety Alert: CDC investigating fast-moving outbreak of Listeria infections
Feb 15 WHO launches new tools to help countries build effective childhood cancer programmes
Feb 15 Biden Administration purchases additional doses of COVID-19 vaccines from Pfizer and Moderna
Upcoming Clinical Trials
NCT04759066Not yet recruiting
The HEALiX™ Intubated Patient (IP) Pilot Study
Conditions: Device Ineffective; Safety Issues
NCT04759144Not yet recruiting
FASter Insulin in Closed-loop Technology in Children
Conditions: Type 1 Diabetes Mellitus
NCT04759157Not yet recruiting
We-PAP: A Couples-based Intervention for Sleep Apnea
Conditions: Obstructive Sleep Apnea
NCT04759183Not yet recruiting
Virtual Reality Experiences for Anxiety and Pain Control
Conditions: Hematopoietic and Lymphoid Cell Neoplasm; Malignant Solid Neoplasm
NCT04759196Not yet recruiting
Generating Evidence on NonEpileptic, Stereotypical and Intermittent Symptoms (NESIS) in Chronic Subdural Hematomas
Conditions: Chronic Subdural Hematoma; Epilepsy; Seizure; Cortical Depression; Cortical Depolarization; Nonepileptic, Stereotypical and Intermittent Symptoms; NESIS
NCT04759248Not yet recruiting
Study With Atezolizumab in Combination With Trastuzumab and Vinorelbine in HER2-positive Advanced/Metastatic Breast Cancer
Conditions: Breast Cancer
NCT04759274Not yet recruiting
Diuretic Tuner Clinical Decision Support
Conditions: Edema; Hypervolemia; Chronic Kidney Diseases; Nephrotic Syndrome
NCT04759313Not yet recruiting
Image Narrative With College Students
Conditions: Depression, Anxiety
NCT04759326Not yet recruiting
Neurorehabilitation Through Hippotherapy of a Brain Stroke
Conditions: Cerebrovascular Accident; Neurorehabilitation; Neuroplasticity; Hippotherapy; Silent Neurofunctional Barriers; Functional Deficit; Cognitive Deficit; Psychological Trauma; Autonomy; Quality of Life; Caregiver Burnout
NCT04759352Not yet recruiting
Telephone Versus In-person Post-test Cancer Genetic Counseling
Conditions: Cancer Gene Mutation
Recent CRA jobs
Operations Strategy Lead - Neuro
Pharmaceutical Product Development (PPD)
United States
Senior Scientist - Formulation - Sterile Suspension
Pharmaceutical Product Development (PPD)
PA-Collegeville-FSP Collegeville PA
Compliance Specialist - GCP - Home Based
Pharmaceutical Product Development (PPD)
Multiple Locations
Regulatory Affairs Manager - Post Approval - Home Based
Pharmaceutical Product Development (PPD)
Multiple Locations
Associate Group Leader - GMP Lab
Pharmaceutical Product Development (PPD)
WI-Middleton-Middleton WI Research Way
AD/Dir Data Analytics
Pharmaceutical Product Development (PPD)
United States
Senior/Lead Centralized Monitoring Analyst
Pharmaceutical Product Development (PPD)
United States
Manager Data Analytics
Pharmaceutical Product Development (PPD)
United States
Principal Centralized Monitoring Analyst
Pharmaceutical Product Development (PPD)
United States
Centralized Monitoring Analyst
Pharmaceutical Product Development (PPD)
https://ichgcp.net/
Guess we will find out.
Huge day tmorrow: US Supreme Court Schedules Pennsylvania Election Case, Sidney Powell’s Michigan Case and Lin Wood’s Georgia Case for Feb 19 Conference
The Supreme Court has scheduled three voter fraud cases to be heard on February 19th. The three cases all revolve around increased mail-in balloting.
The cases involve Pennsylvania, Michigan, and Georgia. The Pennsylvania case was brought by Rep Mike Kelly.
The Georgia case was brought by Lin Wood and Michigan is a case from Sidney Powell. But, even if they win all three it is not going to change anything. Biden will still be president.
President Trump had predicted that the election would be decided by fraud if enhanced mail-in balloting was used.
In Michigan, it could include the fact that ballots were received over three hours aft6er the time limit. There is now definitive proof of that fact after the Gateway Pundit released a video of the delivery.
Even though they won’t change the election results, these cases are important. That is because it can prevent this type of behavior during future elections. Otherwise, we are talking about perpetual cheating and a one-party rule.
The most important thing that could come out of this is the Supreme Court ruling that only state legislatures can set election rules and not crooked SOSs such as Brad Raffensperger.
True, blue states can just pass the mail-in ballot through the legislature but Republicans are never going to win in California or New York, so that won’t matter. But criminals within the Republican party can’t put the fix in like was done in Georgia. No changing of the rules just because the candidate does not go along with establishment politicians.
READ Supreme Court Set to Consider High-Profile Election Lawsuits This Week
Georgia has voter ID laws that were circumvented by Brian Kemp and Raffensperger.
From The Gateway Pundit
The Washington Examiner reported:
The Supreme Court on Friday listed several high-profile election lawsuits for consideration at its mid-February conference.
…
The decision came after the court declined to fast-track all election-related litigation in early January.
In nearly every plea for expedition, lawyers backing former President Donald Trump told the court that if the cases were not heard before President Biden’s inauguration, their success would be unlikely.
But after the court pushed them off, many lawyers said that the challenges were still important and could have long-term implications for election fairness. Trump lawyer John Eastman told the Washington Examiner that even with Trump out of office, it was important to settle the issues raised by expanded mail-in voting
US Supreme Court Schedules Pennsylvania Election Case, Sidney Powell’s Michigan Case and Lin Wood’s Georgia Case for Feb 19 Conference
As Pennyball noted...we owe the RUSSIAN TRIAL TIP...to WSBC...thanks WSBC!
Pennyballz Wednesday, 02/17/21 10:07:06 AM
Re: MackG post# 346493 0
Post #
346555
of 346604
To give credit where credit is due, I believe WSBC and Vlady tipped the Russia trial site many months ago. JFM
TheDane, Great post, should alleviate some of the concerns of some who were dubious.
We need all the information pertenent to this investment not just what they select for us to see.
MinnieM, If we get great trial results why would Leo even look at a term sheet. Governments will be lined up in an agttempt to get the product and money problems will dissappear, maybe, a term sheet for production and distribution?
With all the crap Leo has put up with and the CRIMINAL SHORT ATTACK WE WENT THROUGH, I WOULD LOVE TO SEE A "HUGE" RELEASE IN THE LAST 30 MINUTES OF TODAYS TRADING.
ITS A NOREASTER BREWING, THEY ARE GOING TO NAME IT THE "BRILACIDIN" EXPRESS!!! THE VLUME PICKING UP, SHARE PRICE STARTING TO LIFT. SOON WE WILL BE SAYING THERE SHE BLOWS!!!!!!!!!!!!
FatAlbert1986, ITS IPIX STOCK TIME, ARE YOU READY???
All the loyal supporters of the Brilacidin platform knows, there will be a 10 Q filed and from now to close may be the best time ever to show Leo a little appreciation, and to grab some shares before the lift off. may be minutes, hours, but not days or weeks anymore. GO IPIX!
Today may be the best opportunity to buy IPIX in years, with these prices and we know Leo is going to file the 10Q, possibly after close, just decided to see how many were available under .35 got a bunch good luck to all IPIX longs and may the bird of paridise fly up...............shorts nose.
JFM: Facts, finances, trial situs, PATIENT AVAILABILITY and priority...all differ with every trial indication being tested.
With Brilacidin/Covid we have:
1. Specific time period "next week"... (two weeks ago...for commencement) which was not stated when OM trials...
2. High Priority ...
3. Financial Resources to carry it out...
4. FDA Cooperation (OWS?),Recognition/Encouragement with Investigative New Drug /Fast Track Designation...
5. LAST AND MOST IMPORTANLY....COVID-19 TRAILS have literally MILLIONS of TRIAL CANDIDATES...SPREAD OUT IN EVERY JURSIDSICITION...not a PROBLEM RECRUITING..., but with the "6 month" wait trial...there were Hundreds and BIG PHARMA SUCKED THEM UP...ergo...waited a long time to get candidates for trial...
NOTHING COMPLICATED IN DISTINGUISHING the former OM trial time WITH BRILACIDIN and COVID-19 TRIALS...NO ISSUE WITH TRIAL CANDIDATES...the world makes MILLIONS a DAY!...
...for those who wrongly claim Leo is a publicity hog and put out fluff...(even though Covid PRs have been "chuck full of" Material Facts and information)... LEO...who has obviously held back an announcement of the "publication event" of the "Peer Reveiwed Article" (which some would say is "fluff"), is very likely holding back that announcment and when trials actually commenced, until he receives additional substantial information beyond the commencement of Trials and sites...as well as anticipated "completion" date...all IMO of course...
Personally (reading the tea leaves) I am "hoping" for a huge dump of very positive and material info by Leo...
Brilacidin and Covid-19 CT is not even close to the circumstance surrounding... Brilacidin and OM (at that time)
ps. But we all appreciate your thoughtfulness in giving us the opportunity to distinguish in case other were concerned!
That is wonderful news, hope they can get it into the hospitals and end the misery of thse afflictated with, Covid 19, it attacks the Lungs, Kidneys, Intestional tract and Blood stream with no long term side effects data in, but suspected that there will be some that will be affected for life, just hope there are no roadblocks to stop this from going into production and treatment.
Are there some stop loss orders here?
If they dosed 20 people a day they would be finished with dosages today, right?
Does anyone have any idea how they determine how many would be treated per day, perhaps a swag?
Maybe Brilicidin will re-enter the Vaccine competition and come up with a kill all vaccine eliminating the need for annual shots?
Today we are watching as the democrats facilitate the personal destruction of the one man that could destroy the Golbalist / democrat / Rinos agenda to take full com=ntrol of America, time to stand with our president DONALD J TRUMP and celebrate his movement TO MAKE AMERICA GREAT and "AMERICA FIRST" To me DONALD J TRUMP IS OUR DULY ELECTED PRESIDENT AND I WILL NEVER SUPPORT THE COMMUNIST, SOCIALIST DICTATOR, JOE BIDEN, EXCEPT FOT HIS TRIAL AND HANGING FOR TREASON.
I keep posting to John Carroll keep getting ignored but, the day will come when he will be glad to get acquainted. I did add a 100 today @ .37
Go dp70, tell us more!
I don't believe Leo has fought this battle to just turn over the company products to a BP to profit from, I believe Innovation Pharmaceuticals will become a BP competing on a world wide basis. JMO and based on Leo's grasp of what he has control of. Screw the BP'S!!!
Bet JFM will be glad to know about that also.
Nice post JFM:
yrus603...
You post which is repeating Peter's post that Brilacidin "has not found a bacteria it has not been able to destroy" is of course 100% correct.
To inform newbies of its highly probably success in Human Trials..one only has to point to the thesis IPIX has set out to prove...essential destroying "envelope" structured viruses and bacteria...
IHUB readers can either believe in annonymous short Posters' negative spins or believe in the scientific miracle of the creator of Brilacidin..who is "Dr. William F.DeGrado, referred to by Forbes in 2011 as the “Antibiotic Artisan” and “Genius Chemist”
IPIX is obviously on the final road to proving it out in humans with the Clinical Human Trials, which the company indicated were to begin last week. (...likely a confirmatory PR this week? IMO and my new batch of tea leaves says... Yes)
This summary details the Background and Scientific Rationale for Brilacidin, as a Therapeutic to kill Covid-19 on contact.
Since the company published the thesis...Rutgers Univ. and George Mason Univ U.S. Regional Biocontainment Laboratories have proven out the Destructive Force of Brilacidin against the Covid-19 virus (97% viral reduction), in lab tests...a pre-print "Peer Review Article" has been issued awaiting publication and now FDA has sanctioned trials and granted Fast Track Designation ...to prove out the lab findings in human clinical trials.
This thesis has been substantially proven out over the last 9 months ...the last step is of course the FDA sanctioned Clinical Human Trials which we believe (see last PR) started last week.
Brilacidin....
Quote:
"Computationally-modeled after natural Host Defense Proteins/Peptides (HDPs)1, the“front-line” of defense in the body's innate immune system, Brilacidin is a synthetic,non-peptidic small molecule that kills pathogens swiftly and effectively. Just asimportantly, Brilacidin functions in a robust immunomodulatory capacity, lesseninginflammation and promoting healing.
Brilacidin was modeled on the host defense properties of a frog peptide called magainin based on researchconducted in the late 1980s by Dr. Michael Zasloff. See “New Weapons for the Germ Wars” (pdf) (2002).
Brilacidin (PMX-30063) is Innovation Pharmaceuticals’ defensin-mimetic drug candidate exhibitingsubstantial therapeutic potential in human clinical trials.Innovation Pharmaceuticals, Brilacidin (PMX-30063)/COVID-19 Overview (March 1, 2020) 3 of 22University of Pennsylvania—including by two National Academy of Science members (Dr. William F.DeGrado, referred to by Forbes in 2011 as the “Antibiotic Artisan” and “Genius Chemist”, and Dr.Michael L. Klein), and other scientists..."
link:
https://static1.squarespace.com/static/5715352e20c647639137f992/t/5e5c0bbea72c2f71ab0978ee/158309066
PS. XXXXXXXXXX...the boys from East Setauket and their "outside partners" often play outside of Renniasaunce Technologies...as one of their venture partner said... "that is how I achieved a 758% return on my portfolio last year"...the principals, through (and apparently outside) their entities have been the most successful hedge fund in the world for the past 20 plus years...by working and thinking "outside the box". Think outside the box!
Stay tuned.
PPS. Nice to see the Reddit boys and girls picking up at the same time...the East Setauket boys found that interesting...as does the naked short position here. Ouch!
Mark Lowery, also Songwriter.
They are picking up those low hanging stop orders. The manipulators do it often/
Cracked .40 Symbol
IPIX
LastQuoteHelp
0.405
Change
+0.0746 (+22.58%)
Bid
0.40
Ask
0.405
High
0.405
Low
0.34
Volume
4,671,450
Time (ET)
1:33:29 PM
Schwab has stop loss, check options, you would be crazy (JMO) to put stops on IPIX they always take them out. Crooks!
Thats a mouth full, was it tasty?
With Schwab you can put a sell order in untill cancelled the add all or none in case 0f a run.
LilKahuna, Appreciate your reponse to my post this post is more in the realm of my understanding but I did get the drift of the other post after spending awhile trying to absorb some of what I was readng, Thank you.